Rein Therapeutics, Inc. — Form 8-K
Filed August 27, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On August 21, 2026, Rein Therapeutics received notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing indicated. No specific counterparties, dollar amounts, conditions, or timeline details are provided in the 8-K filing text.
Why this rating
Delisting is existential threat to public company; eliminates market liquidity, institutional access, and likely triggers forced selling. Massive relative to $32.3M market cap.
Extracted items
Tradability signal
NO TRADE
No trade: only ~$22k traded in the last 30 min — too illiquid to enter and exit.
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it negative)
before filing · preread $0.78 ▲ 0.00% | at our read · backfill $0.78 |
The stock had already moved +0.00% between hitting EDGAR and our read finishing — deltas above are measured from our read.
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from August 27, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.